A Multicenter, Randomized, Single-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the Anti-COVID-19 Antibody SA55 for Injection in the Treatment of Patients With Hematological Disorders Who Are Persistently Positive for the Covid-19
Latest Information Update: 25 Aug 2023
At a glance
- Drugs SA 55 (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 25 Aug 2023 New trial record